期刊文献+

应用盐酸氨溴索预防脑出血患者发生医院内肺炎的观察

Application of ambroxol in prevention of nosocomial pneumonia after cerebral hemorrhage
下载PDF
导出
摘要 目的:观察盐酸氨溴索预防脑出血患者发生医院内肺炎的效果。方法:选取内科保守治疗,入院时没有肺部感染的脑出血患者,随机分成两组,治疗组在综合治疗基础上应用盐酸氨溴索,对照组不予盐酸氨溴索,其它治疗一样。对照两组患者医院内肺炎发生率。结果:治疗组(应用盐酸氨溴索组)患者医院内肺炎发生率12.8%;对照组(无盐酸氨溴索组)患者医院内肺炎发生率23.2%。结论:盐酸氨溴索预防脑出血患者医院内肺炎安全有效,值得临床应用推广。 Objective:To observe the therapeutic effect of ambroxol in the prevention of nosocomial pneumonia after cerebral hemorrhage. Methods:The inpatients of eerebral hemorrhage treated with conservative therapy without pulmonary infection were selected and randomly divided into two groups. The treating group was given ambroxol on the basis of the comprehensive treatment,the control group was same as the treating group except ambroxol. Then we compared the nosoeomial pneumonia rates of two groups.Results:The nosocomial pneumonia rate of the treatment group and the eontrol group was 12.8% and 23.2% respectively. Concluslon:Application of ambroxol in the prevention of nosoeomial pneumonia after cerebral hemorrhage is safe and effective.It is worth further clinical application.
出处 《现代医药卫生》 2009年第11期1628-1629,共2页 Journal of Modern Medicine & Health
关键词 盐酸氨溴索 脑出血 医院内肺炎 Ambroxol Cerebral hemorrhage Nosocomial pneumonia
  • 相关文献

参考文献7

二级参考文献25

  • 1王保平,何玉萍.急性脑血管病并发肺部感染108例临床分析[J].疑难病杂志,2002,1(2):83-83. 被引量:44
  • 2Lusuardi M,Cape 1 li A,Carli S,etal.Role of surfactant in chronic obst ructive pulmonary disease:therapeuticimplications.Respiration,1992,59(Suppl 1): 28-32.
  • 3Gillissen A,Nowak D.Characterization of N-acetylcysteine and ambroxol inanti-oxedant therapy.Respir Med,1998,92(4):609-623.
  • 4Houtmeyers E.Effects of drugs on mucus clearance.Eur Respir J,1999,1 4(2):452-467.
  • 5Zasshi NY.Effects of ambroxol HC1 on the guinea pig tracheal mucous secretion andthe rat pulmonary surfactant secretion.Uchida-M,1992,100(4):293-30 0.
  • 6Derelle J,Bertolo HE,Marchal F,et al.Respiratory evolution of patien t withmucoviscidosis treated with mucolytic agents plus dornase alfa.Arch-Pediatr,1998,5(4):371-377.
  • 7Nowak D,Antczak A,Krol M,et al.Antioxidant properties of ambroxol.Fr ee Radic BiolMed,1994,16(4):517-522.
  • 8Zwablo KG,Servais MD,Schmutzler W,et al.Ambroxol inhibits histamine release fromhuman adenoidal mast cells.Inflamm Res,1998,47(Suppl 1):S16-17.
  • 9Dorow P,Weiss T.Modification of mucociliary clearance by a combinati on oftheophylline with ambroxol and of ambroxol in monotherapy.Arzneimittelforschung,1988,38(6):828-830.
  • 10Tamaoki J.Ambroxol inhibits Na+ absorption by canine airway epithe lial cells inculture.J-Pharm-Pharmacol,1991,43(12):841-843.

共引文献468

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部